RHIEOS OPEN RESOURCES - PUBLIC BETA v0.6
10 September 2026

Unless an individual resource says otherwise, RHIEOS-authored material listed by
the RHIEOS Open Resources catalogue as CC BY 4.0 is licensed under the Creative
Commons Attribution 4.0 International licence:
https://creativecommons.org/licenses/by/4.0/

Attribution:
Credit RHIEOS Ventures and the named resource, link to CC BY 4.0, and indicate
whether changes were made.

The Creative Commons licence does not grant rights to RHIEOS trademarks,
software, proprietary scoring logic, protected working methods, confidential
material, third-party content, or data not expressly included in the licensed
resource.

TrialValue® and Dealligence® are registered trademarks in the United Kingdom.

Public in this beta:
- RHIEOS Knowledge ePV™ - Public Executive Summary v0.1
- RHIEOS Enterprise Decision Compass™ - Public Executive Summary v0.1
- RHIEOS AI Assurance for GxP™ - Public Executive Summary v0.1
- TrialValue® Clinical Trial Reference Standard Definitions - May 2026
- CTAide™ Zero-Redline Thinking - catalogue release v1.0
- CTAide™ Balanced Clinical Trial Agreement Model - catalogue release v1.0

Not included in Open Resources:
- Full Knowledge ePV working paper and detailed valuation method
- Enterprise Decision Compass Working Synthesis and detailed architecture
- Detailed AI Assurance rubric, test sequence, scoring/evidence logic and scenario libraries
- Skill-Capability AI Assurance Toolkit
- Full Dealligence® Planner and protected templates/methods